About SPL Pharma
SPL Pharma is a company based in London (United Kingdom) founded in 2016 by Andre Pereira. It operates as a B2B and Marketplace. SPL Pharma offers products and services including Access Programmes, Pharmaceutical Sourcing, Pharmaceutical Logistics, Customs Clearance, and Treatment Compliance. SPL Pharma operates in a competitive market with competitors including Cardinal Health, CNX Therapeutics, Concordia International, Xiel and Bartec Technologies, among others.
- Headquarter London, United Kingdom
- Founders Andre Pereira
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Specialty Pharma Of London Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SPL Pharma
SPL Pharma offers a comprehensive portfolio of products and services, including Access Programmes, Pharmaceutical Sourcing, Pharmaceutical Logistics, Customs Clearance, and Treatment Compliance.
Supports early access to innovative treatments globally
Procures specialty medications for distribution
Handles transport and storage of medicines
Manages import and export compliance
Ensures adherence to treatment protocols
Funding Insights of SPL Pharma
Detailed funding history for SPL Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SPL Pharma
Investment portfolio details for SPL Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SPL Pharma
Detailed financials for SPL Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spl Pharma Comparisons
Peer comparison for SPL Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SPL Pharma
SPL Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, CNX Therapeutics, Concordia International, Xiel and Bartec Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Multiple healthcare products and services are provided to organizations.
|
|
| Locked | Locked | Locked |
Distributor of specialty drugs
|
|
| Locked | Locked | Locked |
Distributes specialty pharmaceutical drugs to healthcare providers.
|
|
| Locked | Locked | Locked |
Specialist nuclear medicine and radiotherapy solutions are distributed.
|
|
| Locked | Locked | Locked |
Mediso: Advanced medical imaging systems and radioactive sources
|
Detailed competitors of SPL Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spl Pharma
Complete news archive for SPL Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SPL Pharma
SPL Pharma was founded in 2016.
SPL Pharma is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Andre Pereira is the current CEO of SPL Pharma. They have also founded this company.
SPL Pharma specializes in the global distribution of specialty medications, offering services like access programs, pharmaceutical sourcing, logistics, customs clearance, and treatment compliance. They operate from offices in Brazil, USA, and UK, bridging healthcare providers and manufacturers. The company supports early market access and collaborates with pharmaceutical partners to ensure timely delivery and compliance in regions like Latin America.
SPL Pharma's top competitors include Cardinal Health, Xiel and CNX Therapeutics.
SPL Pharma offers Access Programmes, Pharmaceutical Sourcing, Pharmaceutical Logistics, Customs Clearance, and Treatment Compliance.